La Jolla Pharma (LJPC) To Be Delisted from NASDAQ, Shareholders Deny Merger with Adamis Pharma (ADMP)
Tweet Send to a Friend
La Jolla Pharmaceutical Company (NASDAQ: LJPC) today announced that it received notification from the Nasdaq Hearings Panel that the Panel ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
